Institut Mérieux, the family holding company of Alain Mérieux, comprises 4 companies dedicated to public health such as prevention, diagnostis, prognosis, treatment and clinical follow-up: Bio Mérieux and Transgene in France; Silliker and ABL Inc. in the United States. It employs 10 000 people worldwide.
For a reasonably open world
